Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 4;30(8):oyae319.
doi: 10.1093/oncolo/oyae319.

The use of wearable technology in studies in older adults with cancer: a systematic review

Jan J Duin  1   2 , Joosje C Baltussen  3 , Gali Albalak  1   2 , Eléonore F van Dam van Isselt  2   4 , Johanneke E A Portielje  3 , Simon P Mooijaart  1   2 , Enrique Soto-Perez-de-Celis  5   6 , Frederiek van den Bos  1   2
Affiliations

The use of wearable technology in studies in older adults with cancer: a systematic review

Jan J Duin et al. Oncologist. .

Abstract

Background: Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most patients with cancer, is poorly defined.

Objective: This systematic review aimed to summarize the current use of wearables in studies in older adults with cancer.

Methods: This systematic review was conducted following the PRISMA guidelines. A systematic search was conducted in PubMed, Embase, Emcare, Web of Science, and Cochrane Library on May 1, 2024. Studies involving wearable devices and patients aged ≥60 years diagnosed with cancer were included. Outcomes reported were study characteristics, wearable outcomes, feasibility and adherence. The mixed method appraisal tool was used to assess the quality of included studies.

Results: A total of 31 publications were included, comprising 1298 older patients. Of these, 12 were pilot/feasibility studies, 12 were observational studies, 6 were randomized controlled trials, and 1 was a cross-sectional study. Most studies used wearable data to measure recovery (19 studies, 61%). Physical activity was the most studied wearable outcome (27 studies, 87%). Adherence to the wearable device was documented in 11 of the 31 studies (35%), with adherence ranging from 74% to 100%.

Conclusions: Our systematic review found wearables were mostly used to measure physical activity, with the most common primary aim of measuring recovery. Most studies reported high adherence, although definitions of adherence were diverse. Our results highlight the need for more and larger studies on wearable technology in older cancer patients, the use of standardized reporting frameworks, and increased participation in research in low- and middle-income countries.

Keywords: cancer; digital health; geriatric oncology; geriatrics; older adult; oncology; systematic review; wearable electronic devices; wearable technology.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Study selection based on PRISMA methods.
See this image and copyright information in PMC

References

    1. Garner WB, Smith BD, Ludmir EB, et al. Predicting future cancer incidence by age, race, ethnicity, and sex. J Geriatr Oncol. 2023;14:101393. https://doi.org/ 10.1016/j.jgo.2022.10.008 - DOI - PubMed
    1. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Tomorrow (version 1.1). International Agency for Research on Cancer; 2024. Accessed June 11, 2024.https://gco.iarc.who.int/today
    1. Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2011;79:205-212. https://doi.org/ 10.1016/j.critrevonc.2010.05.009 - DOI - PubMed
    1. Baltussen JC, de Glas NA, van Holstein Y, et al. Chemotherapy-related toxic effects and quality of life and physical functioning in older patients. JAMA Netw Open. 2023;6:e2339116. https://doi.org/ 10.1001/jamanetworkopen.2023.39116 - DOI - PMC - PubMed
    1. Hamaker ME, Seynaeve C, Wymenga AN, et al. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the omega study of the dutch breast cancer trialists’ group. Breast. 2014;23:81-87. https://doi.org/ 10.1016/j.breast.2013.11.004 - DOI - PubMed

Publication types